Introduction
Cells have developed a stress-induced response to protect themselves from changes in their environment. This response is characterized by the synthesis of a speci®c set of proteins called heat shock proteins (HSP) . Two families of HSP can be distinguished according to their apparent molecular weight. The small HSP family (sHSP) exhibit a monomeric molecular mass ranging between 9 and 42 kDa (Arrigo and Landry, 1994) . Their overexpression enhances the survival of mammalian cells exposed to a variety of death stimuli including heat (Landry et al., 1989) , oxidative stress (Hout et al., 1991; Mehlen et al., 1993) , anticancer drugs (Hout et al., 1991; Garrido et al., 1996 Garrido et al., , 1997 , TNF-a (Mehlen et al., 1995a) , anti-Fas agonistic antibodies and staurosporine (Mehlen et al., 1996a) . The biochemical mechanisms proposed to account for the sHSP protective eect include molecular chaperoning of non-native proteins (Jakob et al., 1993) or capping/decapping enzymes (Lavoie et al., 1993 (Lavoie et al., , 1995 , modulation of the cellular detoxifying machinery to cope with oxidative stress (Mehlen et al., 1996b) and interaction with the cytochrome c-mediated pathway of apoptosis by preventing caspase-9 activation (Garrido et al., 1999) .
sHSP are constitutively expressed in virtually all organisms. They share a conserved sequence in their Cterminus and short phenylalanine-rich stretches near the N-terminus of the protein (Arrigo, 1998) . They have also in common the striking feature of forming high molecular weight oligomeric complexes. For example, in mammalian cells, rodent HSP25 and human HSP27 can form oligomeric complexes ranging from 100 ± 800 kDa. This oligomerization is a highly dynamic process that depends on the physiology of the cell, e.g. HSP27 tends to form small aggregates in starved cells and to reorganize in large structures following serum stimulation (Arrigo et al., 1988; Mehlen and Arrigo, 1994; Kato et al., 1994; Mehlen et al., 1995b) .
Another posttranslational modi®cation that could modulate HSP27 activity concerns its phosphorylation on serine residues that generates more acidic isoforms. Stress-induced phosphorylation of mammalian sHSP is catalyzed by the SAPK2/p38 MAP kinase cascade leading to the activation of the MAPKAP kinases 2 and 3 (Stokoe et al., 1992; Ludwig et al., 1996) . When induced in response to stress, phosphorylation can be detected within a few minutes while changes in expression occur after several hours, suggesting that phosphorylation of the pre-existing constitutively expressed sHSP is a ®rst phase of the stress response while the second phase is characterized by increased expression of the protein, when its phosphorylation is already down-regulated (Landry et al., , 1992 .
Several observations argue for a role of phosphorylation in HSP27 oligomerization. First, phosphorylation of the protein induces the disappearance of the larger aggregates (Kato et al., 1994) . Secondly, HSP27 mutants in which the serine residues have been replaced by alanine amino acids to mimic nonphosphorylable serine residues (alanine mutant), form large oligomers in the cells while the replacement of the serine residues by aspartate residues, that mimic constitutively phosphorylated residues (aspartate mutant), results in a decrease of the multimer size from nearly 800 kDa to below 100 kDa Rogalla et al., 1999) . Third, the phosphorylation of HSP27 is usually detected in the small and mediumsized oligomers of the protein whereas the large structures are mostly unphosphorylated (Mehlen and Arrigo, 1994; Mehlen et al., 1995b) .
Based on in vitro observations, it was suggested that phosphorylation-dependent organization of HSP27 could regulate its biochemical activity. Puri®ed monomers of HSP27 bind actin in solution and inhibit its polymerization (Lavoie et al., 1995) , while the chaperone activity of the protein, as measured by studying the refolding of citrate synthase in vitro, was suggested to be limited to the multimeric complexes (Rogalla et al., 1999) . Experiments performed in transfected cells also suggested that large oligomers were required to protect cells from oxidative stress whereas this activity was down-regulated by phosphorylation-driven dissociation of sHSPs complexes.
It remained unknown how the structural organization of HSP27 is modulated in cells grown in vivo. We have previously shown that HSP27 was neither constitutively expressed nor inducible by various stresses in the REG rat colorectal cancer cell line (Garrido et al., 1998) . In the present study, we stably expressed the wild type, the alanine-and the aspartatemutant of HSP27 in these cells. We show that mutation of phosphorylable serine modulates HSP27 oligomerization in exponentially growing cells in vitro. In these conditions only the aspartate mutant can not form large oligomers and do not demonstrate antiapoptotic activity. In contrast, in cells cultivated at con¯uence or grown in vivo, both the alanine and the aspartate mutant form large oligomers, inhibit apoptosis and increase REG cell tumorigenicity in syngeneic animals. We conclude that cell-cell contacts could modulate the structural organization of HSP27, thereby modifying its antiapoptotic activity.
Results
The aspartate mutant of HSP27 does not form large oligomers in in vitro cultured REG cells
We stably transfected REG cells with either the empty KS2711 plasmid (control) or this plasmid containing the wild type or one of two mutated human HSP27 cDNAs. Each of the coding sequences was under the control of the human HSP27 gene promoter. The two HSP27 gene mutants had been generated in order to substitute the serine 15, 78 and 82 by either three alanines (alanine mutant) or three aspartic acids (aspartate mutant) in HSP27 protein. Expression of this protein was analysed by immunoblot in parental REG cells, one control-transfected and two wild type HSP27-, two alanine mutant HSP27-, and two aspartate mutant HSP27-expressing clones ( Figure  1A To con®rm also that the phosphorylation status of serine 15, serine 78 and serine 83 could modulate HSP27 structural organization in cultured cells, we performed sizing chromatography. In REG cells cultured in vitro, both the wild type HSP27 and its alanine mutant displayed heterogeneous molecular masses comprised between 50 and 650 kDa while the aspartate mutant was recovered as small oligomers, lower than 80 kDa ( Figure 1B ).
HSP27 mutants differentially prevent REG cell apoptosis induced by cytotoxic drugs in vitro
Apoptosis induction was measured in the dierent cell clones exposed for 48 h to cisplatin (2.5 mg/ml) and etoposide (5 mg/ml) which are two commonly used anticancer drugs. When compared with parental REG cells and control-transfected REG cells, REG clones expressing wild type HSP27 and those expressing the alanine mutant demonstrated a 2 ± 4-fold decrease in the number of cells undergoing apoptosis in response to cytotoxic agents (Figure 2 ). In contrast, drug induced apoptosis was not signi®cantly decreased in REG clones expressing the aspartate mutant as compared with parental and control-transfected REG cells (Figure 2) .
When the control-transfected REG cells were exposed to increasing concentration of cisplatin for 48 h, a dose-dependent cleavage of the peptide substrates that mimic caspase-3 (DEVD) and caspase-9 (LEHD) target sequences was observed ( Figure 3A) , suggesting activation of these or related enzymes. The cisplatin-induced cleavage of these peptide substrates observed in control-transfected REG cells was inhibited in REG clones expressing the wild type HSP27 were separated as indicated in the Material and methods section. These multimers were identi®ed by immunoblot using an antihuman HSP27 antibody. The apparent size (kDa) of gel ®ltration markers is indicated and its alanine mutant while it was not in¯uenced by expression of the aspartate HSP27 mutant ( Figure 3A) .
We have recently shown that overexpression of wild type HSP27 inhibited etoposide-induced apoptosis by preventing cytochrome-c mediated activation of caspase-9 and caspase-3 in the U937 human leukemic cell line (Garrido et al., 1999) . To determine whether this inhibition could be con®rmed in REG cells, we used a cell-free system (Garrido et al., 1999) . Addition of cytochrome c (10 mM) and dATP (1 mM) to acellular extracts from control-transfected REG cells induced a time-dependent cleavage of DEVD-AFC and LEHD-AFC substrates ( Figure 3B ). The cytochrome c/dATPinduced cleavage of these caspase substrates was strongly inhibited in acellular extracts from wild typeand alanine mutant-transfected REG cells whereas no inhibition was observed in acellular extracts from aspartate mutant-transfected REG cells ( Figure 3B ).
HSP27 mutations do not modulate REG cell tumorigenicity in vivo
REG cells were obtained from a colon adenocarcinoma induced in a BDIX rat by 1,2 dimethylhydrazine. These cells yielded immunogenic and regressive tumors when injected in syngeneic animals (Martin et al., 1983; Caignard et al., 1985) . The cells were therefore named REG for their regressive phenotype. We have shown that expression of wild type HSP27 in REG cells increased their tumorigenicity in syngeneic hosts (Garrido et al., 1998) . These observations were con®rmed in the present study ( Figure 4A ,B). The subcutaneous injection of either parental REG cells or control-transfected cells yielded small tumors that completely regressed in less than 3 weeks whereas injection of REG cells expressing the wild type HSP27 protein yielded tumors that grew larger and persisted for 7 ± 9 weeks ( Figure 4A ,B). Interestingly, REG cells expressing either the alanine or the aspartate HSP27 mutant demonstrated a tumorigenic eect similar to REG cells expressing the wild type protein ( Figure  4A ,B). Thus, the alanine and the aspartate HSP27 mutants, that displayed distinctly dierent antiapoptotic activities in vitro, demonstrated a similar tumorigenic eect in vivo.
We next analysed the structural organization of HSP27 in tumor cells grown in vivo. As expected from in vitro studies ( Figure 5 , line A), both the wild type HSP27 and the alanine mutant were recovered in the form of small and large oligomers ( Figure 5 , line B). Unexpectedly, aspartate mutant of HSP27 was also recovered from rat tumors as small and large oligomers ( Figure 5 , line B). The formation of large-sized oligomers in these latter tumors could not be due to tumor in®ltration by rat cells expressing high levels of HSP25 since no signi®cant labeling with an antimouse/rat HSP25 was detected in these tumors ( Figure   Figure 2 In¯uence of wild type and mutated HSP27 expression on REG cell sensitivity to drug-induced apoptosis. REG parental cells, REG control-transfected cells and REG cells transfected with either wild type HSP27 (clone Wt7, black bar, and Wt1, shaded bar) or the alanine mutant (clone Ala1, black bar, and clone Ala3, shaded bar) or the aspartate mutant (clone Asp2, black bar, and clone Asp5, shaded bar) were treated with cisplatin (CDDP, 2.5 mg/ml) or etoposide (VP16, 5 mg/ml) for 48 h before assessing the percentage of apoptotic cells from 300 cells counted in triplicate. Means+s.d. are shown (n=3) Figure 3 In¯uence of wild type and mutated HSP27 expression on caspase-3 and -9 activites. (A) REG cells transfected with the empty pKS2711 vector (*) or this vector containing wild type HSP27 cDNA (clone Wt7) (*) or its alanine mutant (clone Ala3) (&) or its aspartate mutant (clone Asp2) (~) were treated with cisplatin for 48 h. (B) Acellular extracts from the cells mentioned above were treated with cytochrome c and dATP, 10 mM and 1 mM respectively, for the times indicated. Caspase-3 and -9 activities were assessed by measuring the cleavage of the DEVD-AFC and LEHD-AFC substrates respectively. Means+s.d. are shown (n=3) 6A,B). When the tumor cells were dissociated and cultured in vitro for 10 ± 15 days, the wild type and alanine-mutant-transfected cells always formed small and large oligomers while only small oligomers could be identi®ed in tumor cells expressing the aspartate mutant ( Figure 5 , line C). These results indicated that the growth of REG cells in syngeneic animals overcome the inability of the aspartate mutant to form large oligomers in vitro.
Identi®cation of apoptotic tumor cells at the site of REG cell injection in the rats indicated that the percentage of apoptotic tumor cells was about 60% in parental and control-transfected REG cell tumors compared with about 20% in wild type-, alanine mutant-and aspartate mutant-transfected REG cell tumors ( Figure 6C,D) . Thus, the aspartate-mutant of HSP27 demonstrated an antiapoptotic eect in vivo similar to that of alanine-mutant and wild type HSP27.
Whereas REG cells induce a speci®c immune response that rapidly triggers the regression of tumors in syngeneic rats, these cells have been shown to lose their regressive phenotype and to induce progressive tumors when injected in nude mice or cyclosporine Atreated BDIX rats (Shimizu et al., 1989) . The experiments in a syngeneic rat model described above were repeated by injecting subcutaneously the various transfected REG clones (control, wild type, alanine mutant and aspartate mutant HSP27) in nude mice. For the four types of cells, all the mice developed similar progressive tumors ( Figure 7A ) and HSP27 structural organization was similar in all tumors, including the presence of both small and large oligomers ( Figure 7B ).
Aspartate mutant of HSP27 forms large oligomers in REG cells grown at high density in vitro
The culture of tumor cells at high density (cell con¯uence) can be used to better reproduce in vitro the conditions of tumor cell growth in vivo (Pelletier et al., 1990) . We have previously shown that cell con¯uence induced HSP27 phosphorylation (Garrido et al., 1997) . Accordingly, HSP27 hyperphosphorylated isoform accumulate in con¯uent wild type HSP27-transfected REG cells ( Figure 8A ). As shown above, despite this phosphorylation, HSP27 formed large oligomers in REG cells. Moreover, as observed in vivo, the aspartate mutant of HSP27 was able to form large oligomers in REG cells grown at con¯uence ( Figure 8B ). Thus, cell-cell contact may generate a signal inducing the formation of large HSP27 oligomers, even when the protein is phosphorylated or serines have been replaced by aspartates to mimic this phosphorylation. To determine the relationship between the formation of large oligomers and the antiapoptotic activity of HSP27, we analysed the ability of cytochrome c and dATP to activate caspases when added to cell-free extracts from aspartate mutant-transfected cells. In cell-free extracts from these cells growing exponentially, cytochrome c/ dATP induced the cleavage of DEVD-AFC and LEHD-AFC peptide substrates whereas no activation was observed in cell-free extracts from these cells grown at high density ( Figure 8C ). We also analysed the ability of cytochrome c and dATP to activate caspases when added to cell-free extracts from control transfected REG cells, which do not express HSP27. We found a similar activity in cell-free extracts from both exponentialy growing and high density cultures ( Figure 8C ). Addition of recombinant HSP27 (rHSP27) to these cell-free extracts inhibited cytochrome c/dATP induction of DEVD-AFC cleavage ( Figure 9A ). Accordingly, rHSP27 is only recovered in the form of large oligomers ( Figure 9B ). These results suggest an important role for HSP27 large oligomers in the resistance of the con¯uent cells to cytochrome c-dependent caspase activation.
Discussion
HSP27 exists in mammalian cells mainly as oligomers with a regular distribution from monomeric and dimeric structures to large oligomers. The largest molecules with a molecular mass of 600 ± 800 kDa could correspond to about 24 HSP27 subunits (Rogalla et al., 1999) . It has been reported that the structure of HSP27 was highly dynamic with small oligomers being in equilibrium with bigger ones (Rogalla et al., 1999; Lambert et al., 1999) . This equilibrium can be shifted toward smaller oligomers as a consequence of HSP27 serine phosphorylation. Human HSP27 contains three sites of phosphorylation at serine residues. The serine 82 corresponds to rodent serine 90 whose phosphorylation was shown to be essential in the reduction of HSP27 complexes to small oligomers (Lambert et al., 1999) . This serine is located in a highly variable region that connects the Cterminal a-crystallin domain of the molecule to its Nterminal domains (De Jong et al., 1988) . It was suggested that the phosphorylation of this serine could destabilize the HSP27 multimers by modifying interactions between some domains of the monomers (Lambert et al., 1999) . The in¯uence of the phosphorylation of serine 15, which is conserved between human and rodent HSP27, on the structure of the protein is more controversial (Rogalla et al., 1999; Lambert et al., 1999) . It was suggested that phosphorylation of serine 15 could modulate interactions of HSP27 with other proteins such as protein kinase B, F-actin or granzyme A (Miron et al., 1991; Benndorf et al., 1994; Konishi et al., 1997; Beresford et al., 1998) rather than the size of HSP27 oligomers (Lambert et al., 1999) . The third serine residue in human HSP27 is 1 mM) . At the times indicated caspase-3 and -9 activities were assessed by cleavage of the speci®c peptide substrates less conserved (e.g. is not present in rodent HSP25) and its role in modulating HSP27 structure remains poorly understood. In the human HSP27 mutants used in the present study, these three serine residues were replaced with either alanine amino acids that mimic nonphosphorylatable serine residues or with aspartate amino acids that mimic constitutively phosphorylated residues Rogalla et al., 1999) . When expressed in exponentially growing REG cells that do not contain endogenous sHSP, the alanine mutant of HSP27 forms small and large oligomers whereas the aspartate mutant only forms small multimers. These initial observations made in exponentially growing REG cells were in accordance with previous reports in cultured cells which showed a reduction in the size of HSP27 complexes after stimulation of phosphorylation (Kato et al., 1994; Landry et al., 1992) and those obtained with similar mutants in other cell systems (Rogalla et al., 1999) .
The main observation of the present study is that the phosphorylation-mediated shift in the size of HSP27 multimers could be overcome when the tumor cells are grown at high density. The possibility that phosphorylation may not be the only mechanism that regulates the size of HSP27 oligomers has already been suggested by previous reports, e.g. the observation that the size of HSP27 oligomers transiently increases in HeLa and L929 cells treated with TNF-a which induces rapid phosphorylation of the protein (Mehlen et al., 1995b (Mehlen et al., ,c, 1997 . However, these observations were dicult to interprete as dierent populations of sHSP could exist in these cell lines and the methods used to detect larger oligomers could also identify small oligomers associated with unfolded proteins (Ehrnsperger et al., 1997; Lee et al., 1997 ). Our conclusion is based on the observation that the aspartate mutant of HSP27 forms large oligomers in REG cells cultured at con¯uence or forming tumors when injected subcutaneously in rodents. Moreover, the wild type HSP27 remained able to form large oligomers in REG cells reaching con¯uence in culturē asks, even though the phosphorylation of HSP27 is increased in colon cancer cells cultured in these conditions (Garrido et al., 1997) .
Con¯uent cultures are better models than actively growing cells for the growth conditions in a solid tumor. We have previously reported that cancer cell sensitivity to most anticancer drugs decreased progressively as these cells reached con¯uence (Pelletier et al., 1990; Dimanche-Boitrel et al., 1992) . Several mechanisms were proposed to account for this con¯uence-dependent resistance, including decreased intracellular drug accumulation, modi®cations of the drug target in con¯uent cells and decreased ability of con¯uent tumor cells to undergo cell death in response to speci®c damage induced by the drug. The present study suggests that the formation of HSP27 large multimers could play a role in the con¯uent-dependent resistance. Interestingly, the aspartate mutant of HSP27 formed large oligomers in REG cells grown in nude mice and in cells cultured at con¯uence as well as in syngeneic BDIX rats. Thus, the formation of large oligomers of the HSP27 aspartate mutant in REG cells grown in syngeneic BDIX rats could not be related to the speci®c immune response induced by tumor cells, e.g. to a cytokine-induced burst of intracellular ROS production (Garrido et al., 1997) . Cell density appears to be mainly responsible for bypassing the control exerted by the phosphorylation of HSP27 to form large multimers, although the mechanisms of this regulation remains currently unexplained. We have proposed recently that the capacity of wild type HSP27 to speci®cally increase REG cell tumorigenicity in syngeneic rats could be related to its antiapoptotic activity in vivo (Garrido et al., 1998) . Accordingly, the ability of cell-cell contacts to overcome phosphorylation-mediated decrease in HSP27 oligomer size correlated with the similar increase of tumorigenicity induced by expression of the wild type and the two mutated HSP27 in REG cells.
Both the protective activities and the chaperone properties of HSP27 were correlated with the ability of the protein to form large oligomers (Rogalla et al., 1999) . Accordingly, in the present study, only the HSP27 proteins that form large oligomers were observed to protect REG cells from apoptosis, either in vitro when exposed to cytotoxic agents or in vivo at the site of tumor growth. Interestingly, by overcoming phosphorylation-driven dissociation of larger oligomers, cell growth at con¯uence in vitro and in vivo restored the ability of HSP27 to inhibit cell death. We have recently shown that HSP27 could interfere with the ®nal pathway to apoptotic cell death by preventing procaspase-9 and procaspase-3 activation, downstream of cytochrome c release from the mitochondria (Garrido et al., 1999) . Accordingly, the wild type HSP27 and the alanine mutant, that forms small and large oligomeric structures, but not the aspartate mutant that only forms small oligomers, prevented caspase-3 and -9 activation induced either by exposure of cultured cells to cisplatin or by treating cell-free extracts with cytochrome c and dATP. These observations suggest that HSP27 can interfere with cytochrome c-induced caspases activation only as a large oligomeric structure. We have shown previously that both the wild type protein and its alanine mutant were also able to modulate radical oxygen species and glutathione levels in growing murine L929 and NIH3T3-ras cells whereas HSP27 aspartate mutant had lost this property . Altogether, these results suggest that the formation of large oligomers is required for several of the mechanisms by which HSP27 was proposed to interfere with apoptotic pathways. However, we cannot rule out that, in some speci®c cell types, the formation of small oligomers could be required for HSP27 protective activity since decreased size of HSP27 multimers is required for intracellular relocalization of the protein (Rogalla et al., 1999) and since HSP27 small oligomers are able to stabilize the cytoskeleton (Lavoie et al., 1995) .
Altogether, these observations indicate that multimerization of HSP27 is dierentially regulated in exponentially growing cultured cells and in cells grown at con¯uence or forming tumors in animals. The protective activity of HSP27 large oligomers against apoptotic stimuli correlated with enhanced cell tumorigenicity in both syngeneic and immune-de®cient animals. It remains to be explained how cell density can overcome the phosphorylation-mediated dissociation of HSP27 to enhance the protective activity of the molecule.
Materials and methods

Cells and reagents
Colorectal cancer REG cells (Martin et al., 1983; Caignard et al., 1985) were grown as monolayers in a controlled atmosphere (378C, 5% CO 2 ) using Ham's F10 medium (BioWhittaker, Fontenay-sous-bois, France) supplemented with 10% (v/v) fetal calf serum. Noncon¯uent cells (exponentially growing cells) were obtained by seeding 2610 6 cells in a 50 ml Falcon¯ask (Falcon, Lincoln Park, NY, USA). About 48% con¯uence was obtained after a 48 h culture. Con¯uent cells were obtained by seeding 10610 6 cells in a 50-ml Falcon Flask. Cisplatin was purchased from Roger Bellon (Neuilly, France). Etoposide (VP16) and puromycin were obtained from Sigma-Aldrich (Saint Quentin Fallavier, France).
Plasmids and transfections
Wild type human HSP27 gene and mutants of this gene in which serine 15, 78 and 82 were substituted with either alanine or aspartate residues were inserted in pKS2711 plasmid vector Rogalla et al., 1999) . Transfection of REG cells was performed by using the Superfect reagent (Quiagen GmbH, Germany). Exponentially growing REG cells were transfected with 5 mg DNA vectors mixed with 20 ml superfect. Transfected cells were treated 48 h later with puromycin (Sigma-Aldrich). Expression of HSP27 in isolated clones was analysed by immunoblot.
Immunoblotting
The mouse anti-human HSP27 and HSP90 monoclonal antibodies were purchased from StressGen (Victoria, Canada). Immunoblots were performed as described (Garrido et al., 1999) . Brie¯y, whole cell extracts were prepared by lysing the cells with 2% SDS, 137 mM NaCl, 2.7 mM KCl, 8 mM Na 2 HPO 4 , and NaCl/P i (pH 7.4) at 688C for 5 min. Protein concentration was measured in the supernatant by using the micro BCA protein assay (Pierce, Asnieres, France). Proteins were separated in a 8 ± 12% SDS-polyacrylamide gel and electroblotted to PVDF membranes (BioRad, Ivry sur Seine, France). After blocking non-speci®c binding sites with 5% non-fat milk in TPBS (PBS, Tween 20 0.1%), blots were incubated with speci®c antibodies, washed in TPBS, incubated 30 min at room temperature with horseradish peroxidase-conjugated goat antimouse antibody (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) and revealed following the ECL Western blotting analysis procedure (Amersham, Les Ullis, France). Autoradiographs were recorded onto X-Omat AR ®lms (Eastman Kodak Co, Rochester). A Biopro®l system (Vilber Lourmat, France) was used for quanti®cation. The analysis was performed within the range of proportionality of the ®lm. All the Western analyses were repeated three times. Two-dimensional electrophoresis was performed as described previously (Arrigo and Welch, 1987) .
Gel filtration analyses
Cells or tumors were washed in PBS, then lysed in a Dounce homogenizer in 50 mM HEPES pH 7.5, 150 mM NaCl, 5 mM KCl, 1 mM EDTA, 10% glycerol, 0.1% Triton X-100 and 1 mM Pefabloc (Merk, Nogent sur Marne, France). The lysates were centrifuged 30 min at 20 000 g at 48C. Then, supernatants were applied to a Sepharose 6B gel ®ltration column (16100 cm) (Pharmacia, Ullis, France), equilibrated and developed in lysis buer devoid of Triton X-100. The fractions eluting from the column were analysed by immunoblot. Molecular mass markers (Merk) that were used to equilibrate the gel ®ltration column included blue dextran (42000 000 Da), thyroglobulin (660 000 Da), apoferritin (443 000 Da), b-amylase (200 000 Da), albumin (66 000 Da) and carbonic anhydrase (29 000 Da).
Cell morphological studies
The percentage of apoptotic cells was determined bȳ uorescence microscopy after staining for 10 min at 378C with Hoechst 33342 at a ®nal concentration of 5 mg/ml. Detached cells were recovered by centrifugation of cell culture supernatant and mixed with the adherent cells recovered by trypsinization. Cells were judged apoptotic on the basis of characteristic chromatin hypercondensation. Cell viability was determined by trypan blue exclusion. Apoptosis in vivo was assessed by the use of a TUNEL assay as described (RoÈ sl, 1992 ).
Activation of cell-free apoptosis
Nuclei-free, mitochondria-free cytosolic extracts were prepared as described (Garrido et al., 1999) . Brie¯y, cells were washed in ice cold PBS, pH 7.2, then in hypotonic extraction buer (HEB: 50 mM PIPES, pH 7.4, 50 mM KCl, 5 mM EGTA, 2 mM MgCl 2 , 1 mM dithiothreitol and 0.1 mM phenylmethylsulfonyl¯uoride) and centrifuged. The pellet was resuspended in HEB, transferred to a 2 ml Dounce homogenizer and lysed. This cell lysate was centrifuged 30 min at 16 000 g at 48C and the clari®ed supernatant was either tested immediately or stored in aliquots at 7808C. Ten ml of cell-free extracts (5 ± 10 mg/ml protein), in the presence or absence of 1 ng of rHSP27 (StressGen), were incubated with 5 mM horse heart cytochrome c (Sigma-Aldrich) and 1 mM dATP (Pharmacia). Caspase-3 and -9 activity in the supernatant was evaluated.
Measurement of caspase-3 and -9 activity
Caspase-3 and caspase-9 activity was assessed by the cleavage of the¯uorometric substrates DEVD-AFC and LEHD-AFC respectively (Calbiochem, San Diego, CA, USA). AFC released from the substrates were excited at 400 nm. Emission was measured at 505 nm.
Cell growth analyses in vivo
Exponentially growing HSP27 wild type-, HSP27 aspartic acid mutant-, HSP27 alanine mutant-and control-transfected REG cells were harvested, washed in PBS, and resuspended to a concentration of 10 6 cells in 200 ml of Ham's medium. These cells were injected s.c. into the anterior thoracic wall of syngeneic BD-IX rats. Tumors were measured with calipers in two perpendicular diameters, and tumor volumes were calculated using the formula v=a 2 6b/2 (a5b). When indicated cells were dissociated from tumors and placed in culture as follows: tumors were cut, washed in HAM's medium to eliminate red cells and dissociated in RPMI medium containing collagenase (2 mg/ml, Sigma-Aldrich) and DNase (0.2 mg/ml, Fluka, St Quentin Falladier, France).
